sábado, 8 de junio de 2024

FDA Approves Imetelstat for Lower-Risk Myelodysplastic Syndromes Sharon Worcester, MA June 07, 2024

https://www.medscape.com/viewarticle/fda-approves-imetelstat-lower-risk-myelodysplastic-syndromes-2024a1000as3

No hay comentarios:

Publicar un comentario